Long Term Care: Medicare Prescription Drug Coverage in Institutions and Our Communities Larry Kocot Vanessa Duran.

Slides:



Advertisements
Similar presentations
1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute Families USA Health Action 2005.
Advertisements

Common/shared responsibilities between jobs.
2012 CMS Fall Conference Part D Coverage Determinations, Appeals & Grievances (CDAG) Jennifer Smith, Director Division of Appeals Policy Medicare Enrollment.
1 Guidance for Organizations Interested in Offering Capitated Financial Alignment Demonstration Plans Medicare-Medicaid Coordination Office Vanessa Duran,
District of Columbia Health Benefits Exchange Authority Network Adequacy Working Group February 14, 2013 Chair: Diane Lewis Vice Chair: Stephen Jefferson.
Facilitated by Alabama Primary Health Care Association Medicaid Transformation.
INTEGRITY ● ACCESS ● VALUE 1 The 340B Drug Pricing Program: The Basics Paul Shank Health & Human Services Consultant, Health Resources and Services Administration.
Medicaid Managed Care for Elderly and Persons with Disabilities Pam Coleman Texas Health and Human Services Commission October 11, 2006.
Donald Mack, M.D. Ohio State University Medical Center Gregg Warshaw, M.D. University of Cincinnati College of Medicine.
April 2012 Policy & Advocacy Briefing Analysis of CMS Consultant Pharmacist Independence Proposal ASCP’s Policy & Advocacy Department
MHAMD Maryland Parity Project and Network Adequacy Report Howard County Behavioral Health Task Force February 12, 2015.
1 HOBBS STRAUS DEAN & WALKER, LLP WASHINGTON, DC | PORTLAND, OR | OKLAHOMA CITY, OK | SACRAMENTO, CA The Indian Addendum Ensuring Meaningful ITU Provider.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
Commonwealth Coordinated Care
Enrollment Guidance for Medicare Part D Plans Presented by America’s Health Insurance Plans (AHIP) and The National Association of Health Underwriters.
Module 10: Pharmacy. 2 Module Objectives After this module, you should be able to: Describe the TRICARE pharmacy benefit List who is eligible for TRICARE.
7/28/05 CMS Presentation to MD Medicaid Advisory Committee 1 Region III State Agency Directors MeetingRegion III State Agency Directors Meeting James Hake.
MEDICARE ADVANTAGE SPECIAL NEEDS PLAN AN OVERVIEW.
Special Needs Plans Susan Nedza, M.D., M.B.A. Chief Medical Officer, CMS Chicago Regional Office March 23, 2006.
Pharmacy and Therapeutics Committee
8th Scope of Work Overview Hospital Workgroup (HoW) May 12, 2005 Suzanne K. Powell, RN, MBA, CCM Director Acute Care.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?
Restrictions on Referrals v Federal law prohibits referrals among providers that have tainted financial relationships v Any arrangement that confers an.
1 Long-term Care Vermont’s Approach Individual Supports Unit Division of Disability and Aging Services Department of Disabilities, Aging & Independent.
Slide -1 Medicare Prescription Drug Benefit Denise S. Stanley, Pharm.D. Atlanta Regional Office Centers for Medicare & Medicaid Services March 17, 2006.
Muskie School of Public Service Institute for Health Policy Evaluating the Impact of Part D on Beneficiaries: Early Lessons Susan Payne Institute for Health.
Improving Care for Medicare-Medicaid Enrollees Medicare-Medicaid Coordination Office Centers for Medicare & Medicaid Services August 19, 2015.
STATE PERSPECTIVES ON IMPLEMENTATION OF MEDICARE PART D: COORDINATING MEDICARE AND MEDICAID COVERAGE THROUGH SPECIAL NEEDS PLANS James M. Verdier Mathematica.
Transitions: Moving Dual Eligibles to Medicare Prescription Drug Coverage Tony Culotta, Director, Appeals and Enrollment Group Babette Edgar, Director,
Module 10: Pharmacy. 2 Module Objectives After this module, you should be able to: Describe the TRICARE pharmacy benefit List who is eligible for TRICARE.
1 Medicare Part D: Cost Management Issues Jack Hoadley Research Professor Georgetown University Health Policy Institute National Academy of Social Insurance.
1 Roadmap to Timely Access Compliance Kristene Mapile, Staff Counsel Crystal McElroy, Staff Counsel Division of Licensing Department of Managed Health.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Medicare Reform: The Pharmacy Perspective John M. Coster, Ph.D., R.Ph. The National Medicare Prescription Drug Congress February 26, 2004.
 2003 Medco Health Solutions, Inc. Implications of the New Medicare Prescription Drug Legislation for Pharmaceutical Manufacturers, PBMs and Health Plans.
Avalere Health LLC | The intersection of business strategy and public policy Formulary Design: Balancing Cost and Access November 1, 2005 Presented By:
Achieving Continuity of Coverage in the Exchange Commonwealth Fund Alliance for Health Reform May 20, 2011.
Guidance Training CFR §483.75(i) F501 Medical Director.
Medicare Advantage Quality Measurement & Performance Assessment Conference April 8, 2008 Medicare Part D Reporting Requirements Alice Lee-Martin, PharmD.
American Society of Consultant Pharmacists America’s Senior Care Pharmacists ® Effects of Medicare Part D on Dual Eligibles in LTC Settings Thomas R. Clark,
Drug & Poison Control center
Humana’s Medication Therapy Management Program Robert McMahan, PharmD, MBA Humana Inc. Third National Medicare Conference October 17, 2006.
© 2009 Delmar, Cengage Learning Chapter 3 Home Health Care.
Special Needs Plans Sandra Bastinelli, MS, RN Acting Director, Division of Special Programs Medicare Advantage Group Center for Beneficiary Choices.
California Department of Public Health / 1 CALIFORNIA DEPARTMENT OF PUBLIC HEALTH Standards and Guidelines for Healthcare Surge during Emergencies How.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
© 2007 NSCLC 1 LAAC Armchair Training Medicare Part D: Accessing Drugs Coverage Determinations, Exceptions, Appeals and Grievances March 8, 2007 Georgia.
Pharmacy Benefit Management (PBM) 101
Pharmacist Opportunities Within a Pharmacy Benefit Manager Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
Medication Therapy Management Part D Programs Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2014.
1 Providing Effective Community- Based LTC in a Managed Care Environment Mary Guthrie, MBA.
MEDICATION USE IN RURAL AMERICA ASSOCIATION UPDATES National Community Pharmacists Association Tina Schlecht, PharmD, MBA Director, Pharmacy Affairs.
What is HIPAA? Health Insurance Portability and Accountability Act of HIPAA is a major law primarily concentrating on the prolongation of health.
II Volga specialized forum "Medicine. Pharmacy"
Promoting consumer access to affordable Prescription drugs
Update on CMS Financial Alignment Initiative and State Integration Efforts Inside and Outside Demonstration Authority Lindsay Barnette Medicare-Medicaid.
Medicare and Medicaid Week 3.
November 1, 2005 Cara M. Jareb, FSA
manatt | phelps | phillips
National Medicare Prescription Drug Congress
Common Insurance Challenges & Access Strategies for people with CF
Implementing and Monitoring Parity
Medicare Part D: Transition, Prior Authorization, & Exceptions
Part D Plan Perspective on Serving Dual Eligibles
HFMA Regulatory Overview
Third National Medicare Congress
AGREEMENT FOR TRANSPARENCY The Case of Mexico
MEDICAID AND MMA ADMINISTRATIVE CHALLENGES: SPECIAL NEEDS PLANS
Medicare Prescription Drug Congress November 2, 2005 MMA Implementation: MMA Part D Long Term Care Implementation.
CENTER FOR MEDICARE ADVOCACY, INC.
Presentation transcript:

Long Term Care: Medicare Prescription Drug Coverage in Institutions and Our Communities Larry Kocot Vanessa Duran

MMA Requirements regarding Access to Part D Drugs in LTC Facilities Section 1860D-4(b)(1)(C)(iv) of the Act requires convenient access to Part D drugs for residents of LTC facilities. Sec. 107 of the MMA requires a report to Congress: –Assessing the current standards of practice, clinical services, and other service requirements generally used for pharmacy services in long-term care settings –Evaluating the impact of those standards with respect to patient safety, reduction of medication errors and quality of care.

Regulatory Access Standards for LTC Pharmacies (§ (a)(5)) Plans must demonstrate convenient access to LTC pharmacies –Offer standard contracting terms & conditions to all I/T/U pharmacies in service area –Must contract with “any willing pharmacy” Standard terms and conditions must conform with certain performance and service criteria for the provision of LTC pharmacy services established by CMS in further guidance CMS has provided separate guidance regarding how convenient access to LTC pharmacies will be assessed

Regulatory Network Access Standards for LTC Pharmacies (§ (a)(5)) Anticipated benefits of our LTC access policy: –Plans may negotiate more competitive market rates with LTC pharmacies –LTC facilities will likely be able to select just one LTC pharmacy to serve their residents –May allow LTC facilities to negotiate more competitive rates for additional services for their residents from LTC pharmacies

LTC Guidance: LTC Pharmacy Performance and Service Criteria –Comprehensive inventory and inventory capacity –Pharmacy operations and prescription orders –Special packaging –IV medications –Compounding/alternative forms of drug compositions –Pharmacist on-call service –Delivery service –Emergency boxes –Emergency logbooks –Miscellaneous reports, forms, and prescription ordering supplies

LTC Guidance: Convenient Access Convenient access to LTC pharmacies for 2006: –Work plan –Performance and service criteria –Contracting with any willing pharmacy –Attestation of convenient access and list of network LTC pharmacies by August 1, 2005 Convenient access in future contract years may look at: –Enrollment/disenrollment rates –Complaints –Linking beneficiaries to LTC pharmacies to verify LTC pharmacy capacity

LTC Guidance: Formulary Plans must have a single formulary for all enrollees Plans must establish an appropriate transition process for new enrollees: –Procedures for medical review of non-formulary drugs –Procedures for switching enrollees to therapeutically equivalent alternatives failing affirmative medical necessity determination –Temporary one-time supply fills recommended –Documentation of range and circumstances impacting transition timeframes –Other transition methods (e.g., contacting enrollees in advance of initial effective date of enrollment)

LTC Guidance: Exceptions & Appeals We expect plans to consider interrelationship between LTC facility, LTC pharmacy, attending physician, and relevant laws and regulations in establishing grievance, coverage determination, and appeals processes Part D sponsors must clearly articulate financial responsibility of plans when Part D requirements and Medicare conditions of participation (COPs) conflict Recommend that plans consider one-time temporary or emergency supply process as a stopgap while an exception or appeal request is in process Regulations allow an appointed representative to act on an individual’s behalf